M1 Kliniken AG (M12) - Total Assets
Based on the latest financial reports, M1 Kliniken AG (M12) holds total assets worth €203.28 Million EUR (≈ $237.66 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See M1 Kliniken AG net assets for net asset value and shareholders' equity analysis.
M1 Kliniken AG - Total Assets Trend (2013–2024)
This chart illustrates how M1 Kliniken AG's total assets have evolved over time, based on quarterly financial data.
M1 Kliniken AG - Asset Composition Analysis
Current Asset Composition (December 2024)
M1 Kliniken AG's total assets of €203.28 Million consist of 44.5% current assets and 55.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 11.4% |
| Accounts Receivable | €17.62 Million | 9.4% |
| Inventory | €36.13 Million | 19.2% |
| Property, Plant & Equipment | €12.91 Million | 6.9% |
| Intangible Assets | €25.37 Million | 13.5% |
| Goodwill | €62.09 Million | 33.1% |
Asset Composition Trend (2013–2024)
This chart illustrates how M1 Kliniken AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of M1 Kliniken AG.
Key Asset Composition Facts
- Current vs. Non-Current Assets: M1 Kliniken AG's current assets represent 44.5% of total assets in 2024, an increase from 7.7% in 2013.
- Cash Position: Cash and equivalents constituted 11.4% of total assets in 2024, up from 2.7% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 46.0% of total assets, a decrease from 62.0% in 2013.
- Asset Diversification: The largest asset category is goodwill at 33.1% of total assets.
M1 Kliniken AG Competitors by Total Assets
Key competitors of M1 Kliniken AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
M1 Kliniken AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.06 | 1.76 | 11.00 |
| Quick Ratio | 1.35 | 1.10 | 10.68 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €50.18 Million | €42.96 Million | €56.09 Million |
M1 Kliniken AG - Advanced Valuation Insights
This section examines the relationship between M1 Kliniken AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.56 |
| Latest Market Cap to Assets Ratio | 1.60 |
| Asset Growth Rate (YoY) | -11.8% |
| Total Assets | €187.87 Million |
| Market Capitalization | $300.08 Million USD |
Valuation Analysis
Above Book Valuation: The market values M1 Kliniken AG's assets above their book value (1.60x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: M1 Kliniken AG's assets decreased by 11.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for M1 Kliniken AG (2013–2024)
The table below shows the annual total assets of M1 Kliniken AG from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €187.87 Million ≈ $219.65 Million |
-11.78% |
| 2023-12-31 | €212.95 Million ≈ $248.96 Million |
+8.08% |
| 2022-12-31 | €197.02 Million ≈ $230.34 Million |
-0.55% |
| 2021-12-31 | €198.11 Million ≈ $231.61 Million |
+4.96% |
| 2020-12-31 | €188.74 Million ≈ $220.66 Million |
+103.35% |
| 2019-12-31 | €92.81 Million ≈ $108.51 Million |
+33.44% |
| 2018-12-31 | €69.55 Million ≈ $81.32 Million |
+37.54% |
| 2017-12-31 | €50.57 Million ≈ $59.12 Million |
+57.11% |
| 2016-12-31 | €32.19 Million ≈ $37.63 Million |
-3.02% |
| 2015-12-31 | €33.19 Million ≈ $38.80 Million |
-14.25% |
| 2014-12-31 | €38.70 Million ≈ $45.25 Million |
+72.95% |
| 2013-12-31 | €22.38 Million ≈ $26.16 Million |
-- |
About M1 Kliniken AG
M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; abdomino… Read more